Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings: Great promise but some early caution

AIDS

Volumn 28, Issue 4, 2014, Pages 599-601

  Shaffer, Nathan ^a   Abrams, Elaine J ^b   Becquet, Renaud ^c,d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Department of Medicine   (United States)

^c INSERM   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; NEVIRAPINE; TENOFOVIR; ZIDOVUDINE;

BREAST FEEDING; CD4 LYMPHOCYTE COUNT; HEALTH PROGRAM; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFANT FEEDING; MALAWI; MEDICATION COMPLIANCE; MOTHER CHILD RELATION; NOTE; PREGNANT WOMAN; PRIORITY JOURNAL; RAPID TEST; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; WEANING;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BREAST FEEDING; FEMALE; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84893272379     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000144     Document Type: Note

References (18)

1. Bolu OO, Allread V, Creek T, Stringer E, Forna F, Bulterys M, et al. Approaches for scaling up human immunodeficiency virus testing and counseling in prevention of mother-to-child human immunodeficiency virus transmission settings in resourcelimited countries. Am J Obstet Gynecol 2007; 197 (Suppl 3): S83-S89.
2. Wettstein C, Mugglin C, Egger M, Blaser N, Vizcaya LS, Estill J, et al. Missed opportunities to prevent mother-to-childtransmission: Systematic review and meta-analysis. AIDS 2012; 26:2361-2373.
3. World Health Organisation. Guidance on provider-initiated HIV testing and counselling in health facilities. 2007. 4; whqlibdoc. who.int/publications/ 2007/9789241595568-eng.pdf [accessed 18 October 2013].
4. Becquet R, Bequet L, Ekouevi DK, Viho I, Sakarovitch C, Fassinou P, et al. Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIVinfected mothers in Cote dIvoire. PLoS Med 2007; 4:e17.
5. Bork K, Cames C, Cournil A, Musyoka F, Ayassou K, Naidu K, et al. Infant feeding modes and determinants among HIV-1-infected African Women in the Kesho Bora Study. J Acquir Immune Defic Syndr 2013; 62:109-118.
6. Rollins NC, Becquet R, Bland RM, Coutsoudis A, Coovadia HM, Newell ML. Infant feeding, HIV transmission and mortality at 18 months: The need for appropriate choices by mothers and prioritisation within programs. AIDS 2008; 22:2349-2357.
7. De Vincenzi I. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): A randomised controlled trial. Lancet Infect Dis 2011; 11:171-180.
8. Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie P, et al. Peripartum and postnatal HIV transmission in West Africa: Evaluation of a two-tiered Approach. PLoS Med 2007; 4:e257.
9. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. 2013. http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index. html [accessed 18 October 2013].
10. Ahmed S, Kim MH, Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: A review of the evidence for the Option BR approach. Curr Opin HIV AIDS 2013; 8:474-489.
11. Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: Time for a public health approach. Lancet 2011; 378:282-284.
12. WHO. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Programmatic update. 2012. http://whqlibdoc.who.int/hq/2012/WHO-HIV-2012.6-eng.pdf [accessed 16 August 2012].
13. Coutsoudis A, Goga A, Desmond C, Barron P, Black V, Coovadia H. Is Option BR the best choice Lancet 2013; 381:269-271.
14. Centers for Disease Control and Prevention (CDC). Impact of an innovative approach to prevent mother-to-child transmission of HIV-Malawi, July 2011-September 2012. MMWR Morb Mortal Wkly Rep 2013; 62:148-151.
15. Malawi Ministry of Health. Quarterly reports with updates on all antiretroviral therapy programmes [cited 18 October 2013]. http://www. hivunitmohmw.org/Main/AntiretroviralTherapy [accessed 18 October 2013].
16. Tenthani L, Haas AD, Tweya H, Jahn A, Van Oosterhout JJ, Chimbwandir F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (Option BR) in Malawi. AIDS 2014; 28:589-598.
17. Stringer EM, Ekouevi DK, Coetzee D, Tih PM, Creek TL, Stinson K, et al. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. JAMA 2010; 304:293-302.
18. Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and highincome countries: A systematic review and meta-analysis. AIDS 2012; 26:2039-2052.